Covered stents (CSs) remain essential devices in catheterization laboratories because they offer the only alternative to emergency surgery to rescue patients with coronary Ellis III grade ruptures [ 1 ], rapidly filling the pericardial space, more common in heavily calcified stenoses and chronic total obstructions (CTO) [ 2 , 3 ]. Still, unlike in peripheral interventions, where aneurysmal pathology is more frequent and the risk of thrombosis after large covered stents is low, our knowledge of the long-term fate after CSs implantation in coronary arteries is limited.